Are women with MS at an increased risk of cervical dysplasia and/or cancer?
- Research Opportunity
- Masters by Research, Honours, Master of Biomedical Science
- Project Status
- Medicine and Radiology
- Royal Melbourne Hospital
|Dr Anneke van der Waltfirstname.lastname@example.org|
|Dr Vilija Jokubaitis|
Disease modifying treatments in MS are used in the majority of patients with relapsing forms of multiple sclerosis. Many of the available treatments are relatively new and the longterm side-effects of these drugs are not known. The risk of cervical dysplasia and cervical cancer due to HPV is increased in immuno-deficient women through a variety of mechanisms.
This study aims to collect MS disease specific factors, exposure to disease modifying treatments and risk factors for cervical dysplasia (smoking, vaccination status, sexual partners). Data will be matched with pap smear results stored at the Victorian Cervical Cytology Registry. The project is suited to a motivated student interested in a clinical project.
Faculty Research Themes
School Research Themes
Masters by Research, Honours, Master of Biomedical Science Graduate Research Students who are interested in joining this project will need to consider their elegibility as well as other Graduate Research requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.